<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01937520</url>
  </required_header>
  <id_info>
    <org_study_id>2012002417</org_study_id>
    <nct_id>NCT01937520</nct_id>
  </id_info>
  <brief_title>Acupuncture for Reduction of Inflammation</brief_title>
  <official_title>Acupuncture for Reduction of Inflammation in Thyroid and Parathyroid Surgery: Randomized, Prospective Double Blind Pilot Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rutgers, The State University of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rutgers, The State University of New Jersey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being done because the investigators wish to study ways to improve recovery
      after surgery. Injury, including surgical injury, causes inflammation. Inflammation is the
      body's attempt to protect itself and to start the healing process. Some surgical
      complications are related to the body's natural inflammatory response. Although mainly a
      healing response, inflammation can also have side effects which delay recovery. The
      investigators wish to determine the effect of acupuncture on post-operative surgical pain. An
      increase in pain after surgery can cause distress for patients. Acupuncture is an alternative
      medicine methodology originating in China that treats patients by manipulating thin, solid
      needles that have been inserted into acupuncture points in the skin. Acupuncture has been
      used for the reduction of pain. The investigators would like to see if acupuncture during
      surgery can provide a lower level of pain, reduced pain medication requirement, and a lower
      incidence of nausea and vomiting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acupuncture has traditionally been used in Asia and is increasingly popular in Western
      countries to treat a variety of conditions (1). In recent years, acupuncture is widely used
      to assist in improving pain and inflammatory diseases (2). However, the mechanisms associated
      with these treatments that influence the immune system are not yet understood.

      Cytokines like interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and interleukin-6
      (IL-6) are proposed to be proximal mediators in the early stages of inflammation. They
      modulate many of the early inflammatory response that is induced by tissue injury, infection,
      or an immune stimulus (3, 4). Although the response is a critical first line of defense
      against pathogens, when the inflammatory reaction is uncontrolled, it can cause more damage
      to the host than the initial stimulus. TNF-α is a pro-inflammatory cytokine that is very
      effective in local and systemic inflammations (5). In addition, TNF-α increases the
      production of other inflammatory cytokines such as IL-1β, IL-6, and interleukin-18 (IL-18)
      during the inflammatory process. Therefore, it initially brings infections under control,
      produces coagulation in the damaged tissue, and stimulates tissue improvement. An excessive
      increase of TNF-α level causes an extreme immune reaction and contributes to the development
      of atherosclerosis, shock, endotoxemia, and chronic inflammatory diseases such as rheumatoid
      arthritis, ankylosing spondylitis, and inflammatory bowel disease (5-7). Yim and colleagues
      reported a decrease in increased serum TNF-α, IL-6, and interferon gamma levels by arthritis
      as a result of electroacupuncture treatment (9). In a rat model for ulcerative colitis,
      acupuncture inhibited the expression of IL-1β and IL-6 (10). It has been reported that
      acupuncture significantly reduces complete Freund's adjuvant-induced hind paw edema and mouse
      air pouch inflammation (11, 12). Acupuncture could also improve immune dysfunction after
      surgical stress both in human and animals (13, 14).

      Some cytokines are pro-inflammatory, but others are anti-inflammatory (3). The
      anti-inflammatory interleukins comprise interleukine-4 (IL-4) and interleukine-10 (IL-10) and
      these are considered as mediating the down-regulation of immune-inflammatory conditions.
      Acupuncture for treatment of the ulcerative colitis rats is possibly related with the
      decrease of IL-1β, a pro-inflammatory cytokine, and the increase of IL-4, an
      anti-inflammatory cytokine (15).

      Therefore, it is reasonable to expect that the protective action of acupuncture is exerted by
      the modulation of pro- and anti-inflammatory cytokines. The restoration of balance between
      pro- and anti-inflammatory cytokines by acupuncture gives into the mechanisms underlying the
      immune-modulation effect of acupuncture.

      Inflammation is associated with pain hypersensitivity that is produced by the release of
      inflammatory mediators. The pro-inflammatory cytokines play an essential role in pain
      sensitization (16). The peripheral effects of these cytokines on sensitizing nociceptors have
      been well documented (16). Post-operative surgical pain can cause significant physiologic and
      psychologic distress for patients. An increase in pain duration and intensity after surgery
      can contribute to a variety of complications, including delayed ambulation, pulmonary and
      thromboembolic complications, increased length of hospital stay, and generalized distress and
      anxiety. Effective post-surgical pain relief requires a multidisciplinary effort and
      influences patients' satisfaction with care and successful outcomes (17). Acupuncture has
      been used for a long time for the reduction of pain. In light of these factors, the use of
      acupuncture that may allow a reduction in the dosage of conventional analgesics is highly
      valuable because it can lower the incidence of possible adverse effects. Several trials have
      demonstrated that patients receiving acupuncture prior to surgery have a lower level of pain,
      reduced opioid requirement, a lower incidence of post-operative nausea and vomiting, and
      lower sympatho-adrenal responses (18). The local release of β-endorphin could be responsible
      for the analgesic effect. β-endorphin may be interacting with cytokines to reduce pain and
      acupuncture may amplify the interaction between β-endorphin and cytokines.

      The investigators will ask patients undergoing thyroid and parathyroid surgery to determine
      how acupuncture restores a balance of pro- and anti-inflammatory cytokines to reduce pain and
      inflammation before, during, and after surgery. The effect of acupuncture on post-surgical
      pain will be evaluated.

      Protocol A prospective randomized, double-blinded (patient and data collector), study of 30
      patients undergoing thyroid or parathyroid surgery under general anesthesia, will be
      conducted to compare the effects of acupuncture on the levels of circulating cytokines
      between acupuncture group and control group. The control group is to receive the same
      anesthetic and surgical techniques without the acupuncture.

      The principal investigator will use the Large intestine 4 (LI-4), the Large intestine 11
      (LI-11), and the Stomach 36 (ST-36) acupuncture points (acupoints). LI-4 and LI-11 acupoints
      lie on the Large intestine meridian (pathway). The Large intestine meridian runs through the
      frontal neck region including the thyroid. LI-4 point is located in the middle of the 2nd
      metacarpal bone on the radial side and LI-11 point is located at the lateral end of the
      transverse cubital crease. Acupuncture on these two acupoints showed increased
      immune-modulatory effects including cytotoxicity of leukocytes (19, 20). ST-36 point is
      located on the outside of the anterior crest of the tibia and just below the knee. This point
      is the most commonly used to reduce general body pain (21). The acupuncture procedures will
      be performed by an anesthesiologist licensed to do so.

      After cleaning the skin with alcohol swabs, an acupuncture needle (30 Gauge, 0.30X30
      millimeter, Mac Spring Handle Needle, Korea) will be swiftly inserted approximately 5-10 mm
      deep bilaterally at both LI-4 and LI-11 acupoints of each arm and at ST-36 acupoint of each
      leg. Electroacupuncture (EA) will be delivered by a stimulator (Digital Electronic
      Acupunctoscope 4-C, Model AWQ-104L™ Hong Kong, Dist by Lhasa Medical, Weymouth, MA) via
      electrodes from the stimulator at 10 Hz frequency with the electrical current of continuous
      wave. This setting showed significant anti-hyperalgesic effects in a rat inflammation model
      (22, 23) and also inhibited the up-regulation of IL-1β and its messenger Ribonucleic acid
      (mRNA) compared to the sham control in a rat model of bone cancer pain (24). EA is a
      particularly therapeutic method in which a small electrical charge is applied to acupuncture
      needles inserted at the acupoints. EA has the advantage of combining the stimulation of both
      needles and electricity compared to manual acupuncture alone, and may potentiate the effect
      of the acupuncture treatment along the meridians. One end of electrode will be attached to
      the acupuncture needle handle at LI-4 acupoint, and another end will be attached to the
      acupuncture needle handle at LI-11acupoint bilaterally. For EA on ST-36, one end of electrode
      will be attached at the right side ST-36 acupoint and another end will be attached at the
      left side ST-36 acupoint. A symmetrical biphasic wave will be delivered to the electrodes so
      that the electrode will be alternately positive and negative and the bilateral LI-4, LI-11,
      and ST-36 acupoints will be stimulated alternately. Mild muscle twitching will be observed.

      The investigator will stimulate the acupoints as follows:

        1. EA will be performed for 30 min (a time that is similar to that used in clinical
           practice).

        2. EA will stop after 30 min of the treatment, but leave the needles on the acupoints.

        3. Subsequently, EA will be re-initiated for an additional 30 min.

      This advanced EA technique showed more increased nitric oxide production in the second
      interval of EA than that of the first interval, and reduced blood pressure at the end of the
      second interval in our preliminarily study (25). In addition, this technique increased
      transient receptor potential vanilloid type-1 receptor immunoreactivity in the acupoints
      compared to that of non-acupoints (26). The advanced EA treatment will be started just before
      the beginning of surgery.

      At the conclusion of the surgical procedure, the acupuncture needles will be removed. The
      subjects will be awakened and after meeting the criteria for extubation will be transferred
      to the Post Anesthesia Care Unit (PACU).

      Blood Samples A second intravenous line will be placed in the other arm after the induction
      of anesthesia and prior to surgical incision to collect blood samples. 15 ml of blood will be
      collected at three time points: (1) preinduction, (2) just after the advanced EA treatment
      (3) after arrival in PACU and prior to additional medication administration (approximately
      120 minutes post preinduction sample). These specimens will be placed into vacutainer tubes
      with no anti-coagulant. Blood will be drawn with a syringe attached directly to the
      angiocatheter which has been placed intravenously. To prevent hemolysis, blood will be
      transferred without a needle, to a vacutainer whose top has been removed. The vacutainer top
      will be replaced and specimens labeled with study name, subject's study ID number, sample
      number, and dated. Bloods from the first two time points will be kept refrigerated until the
      final sample is obtained postoperatively. Blood samples will be transported to the Institute
      for Complementary and Alternative Medicine/School of Health Related Professions
      Interprofessional Health Research Laboratory within the Department of Clinical Lab Sciences
      (G level, Bergen Building, 65 Bergen St., Newark). They will be centrifuged, serum removed,
      aliquoted, and stored at -80C until analysis.

      Laboratory Analysis Samples will be analyzed for levels of cortisol, C-reactive proteins, and
      cytokines interleukin (IL)-1α, IL-1β, IL-1ra, IL-2, IL-6, IL-8, IL-10, and TNF-α, by
      appropriate methods, including ELISA or multiplex fluorescent bead technology. All samples
      will be run in duplicate on with plates and reagents of the same lot. In addition we will
      test Adrenocorticotropic hormone (ACTH), glucose and insulin to evaluate the response of the
      stress. Any samples varying greater than 15% between duplicates will be repeated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduced Pain Medication Requirement</measure>
    <time_frame>amount of pain medication provided in PACU</time_frame>
    <description>analgesia provided in Post Anesthesia Care Unit PACU)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Acuity Score (VAS)</measure>
    <time_frame>arrival in PACU to 2 hours post operatively</time_frame>
    <description>VAS is a self reported pain scale with a score ranging from 0 to 10. 0= no pain, 10=worst pain possible. Multiple pain sacores were recorded. single value is reported by average</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Morphine Equivalent</measure>
    <time_frame>PACU, day 1 , day 2, day 3</time_frame>
    <description>equivalent doses of morphine for analgesic relief. All analgesic treatments were converted to morphine equivalents in milligrams.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Levels</measure>
    <time_frame>PACU, day 1 , day 2, day 3</time_frame>
    <description>Visual Acuity scale 0=no pain 10= worst pain possible</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>(ACTH )Adrenocorticotropic Hormone</measure>
    <time_frame>serum ACTH from baseline/preoperatively,intraoperatively, upon arrival in PACU</time_frame>
    <description>All blood samples were collected during general anesthesia, the first prior to surgical incision and electroacupuncture, the second 60 minutes after incision time and at the completion of electroacupuncture, the third after arrival in PACU but before the administration of analgesia. The data below represents female patients only</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morphine Equivalent</measure>
    <time_frame>PACU to 2 hours post op</time_frame>
    <description>All analgesic treatments were converted to morphine equivalents in milligrams .</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morphine Equivalent (mg)</measure>
    <time_frame>PACU arrival to 2 hours post op</time_frame>
    <description>morphine equivalent to analyze whether body weight affected the efficacy of electroacupuncture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Quality of Recovery Scale</measure>
    <time_frame>Day 1, 2, 3</time_frame>
    <description>Modified patient self reported scale with 9 questions regarding general well being including ability to eat, free from constant pain, able to manage activities of daily living. 0= worst possible score and 18=best outcome score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cortisol</measure>
    <time_frame>prior to surgical incision, 1 hour following incision, after arrival in PACU</time_frame>
    <description>All blood samples were collected during general anesthesia, the first prior to surgical incision and electroacupuncture, the second 60 minutes after incision time and at the completion of electroacupuncture, the third after arrival in PACU but before the administration of analgesia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose</measure>
    <time_frame>serum glucose from baseline to PACU arrival</time_frame>
    <description>the first two blood samples were collected during general anesthesia, the first prior to surgical incision and electroacupuncture, the second 60 minutes after incision time and at the completion of electroacupuncture, the third after arrival in PACU but before the administration of analgesia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tumor Necrosis Factor (TNF)</measure>
    <time_frame>preoperatively-intraoperatively-postoperatively</time_frame>
    <description>First two blood samples were collected during general anesthesia, first prior to surgical incision and Electro-acupuncture (EA), 2nd 60 minutes after incision and EA, third after arrival in PACU but before administration of analgesia. TNF is a critical pyrogen produced during acute phase of a reaction to trauma.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>iNTERLEUKIN (IL-2 and IL-4)</measure>
    <time_frame>Preoperatively-intraoperatively-postoperatively</time_frame>
    <description>both are IL-2 and IL-4 are critical cytokines regulating the cellular response to induce cellular versus hormone immunity. First two blood samples were collected during general anesthesia: first prior to surgical incision and electroacupuncture, second 60 minutes after incision and electroacupuncture and the 3rd after arrival in PACU but before analgesia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IL-6</measure>
    <time_frame>Preoperatively-intraoperatively-postoperatively</time_frame>
    <description>First two blood samples were collected during general anesthesia, first prior to Surgical incision and EA, 2nd 60 minutes after incision and EA and the 3rd after arrival in PACU but before administration of analgesia. IL-6 is a critical inflammatory cytokine produced during the acute phase of reaction to trauma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IL-10</measure>
    <time_frame>Preoperatively-intraoperatively-postoperatively</time_frame>
    <description>IL-10 is an anti-inflammatory cytokine marker. First two blood samples were collected during general anesthesia, first prior to surgical incision and EA, 2nd 60 minutes following incision and EA, and the third after arrival in PACU but before administration of analgesia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TGFB1</measure>
    <time_frame>Preoperatively-intraoperatively-postoperatively</time_frame>
    <description>TGFB1 is a pleiotropic factor regulating the immune system and healing. First two blood samples drawn under general anesthesia, first prior to surgical incision and EA, the 2nd 60 minutes after incision and EA, third after arrival in PACU but before administration of analgesia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Insulin Level</measure>
    <time_frame>preoperative and postoperative</time_frame>
    <description>to determine if electroacupuncture reduced hyperglycemia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Thyroid or Parathyroid Surgery</condition>
  <arm_group>
    <arm_group_label>acupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>acupuncture will be administered after induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>device</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>no acupuncture will be done on this group of subjects</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>acupuncture</intervention_name>
    <description>One half of subjects will receive a standardized acupuncture regiment</description>
    <arm_group_label>acupuncture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>no acupuncture</intervention_name>
    <description>placebo</description>
    <arm_group_label>device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Not currently pregnant or beast feeding

          2. American Society of Anesthesiologists physical status of 1, 2, 3 as determined by your
             anesthesiologist

          3. Patients have a working telephone

        Exclusion Criteria:

          1. Uncontrolled high blood pressure (systolic &gt; 180 mm Hg (millimeters of mercury),
             diastolic&gt;110 mm Hg

          2. Heart block &gt;than first degree

          3. Pacemaker

          4. Cardiac muscle is at risk for injury

          5. not English speaking

          6. Acupuncture within the last 30 days

          7. If you have taken ibuprofen, advil aleve, motrin or aspirin with 5 days of the
             scheduled surgery.

          8. Prior history of drug or alcohol dependence

          9. If you are unable to feed, dress or bathe yourself

         10. If your breathing tube is not removed prior to leaving the operating room.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dennis Grech, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rutgers/NJMS</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David D Kim, PhD LaC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rutgers/NJMS</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alex Bekker, MD. PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Rutgers/NJMS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Grech D, Li Z, Morcillo P, Kalyoussef E, Kim DD, Bekker A, Ulloa L. Intraoperative Low-frequency Electroacupuncture under General Anesthesia Improves Postoperative Recovery in a Randomized Trial. J Acupunct Meridian Stud. 2016 Oct;9(5):234-241. doi: 10.1016/j.jams.2016.03.009. Epub 2016 Apr 4.</citation>
    <PMID>27776761</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 24, 2013</study_first_submitted>
  <study_first_submitted_qc>September 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2013</study_first_posted>
  <results_first_submitted>December 2, 2015</results_first_submitted>
  <results_first_submitted_qc>October 4, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 23, 2016</results_first_posted>
  <last_update_submitted>March 15, 2017</last_update_submitted>
  <last_update_submitted_qc>March 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>acupuncture</keyword>
  <keyword>inflammation</keyword>
  <keyword>thyroid</keyword>
  <keyword>parathyroid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Thyroid Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>data is in results section</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited in a Same Day Surgery Suite at a academic medical center. The first participant was enrolled on 7/2/13 and last patient enrolled on 7/15/14.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Acupuncture</title>
          <description>acupuncture will be administered after anesthesia induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes.
acupuncture: One half of subjects will receive a standardized acupuncture regiment</description>
        </group>
        <group group_id="P2">
          <title>Sham</title>
          <description>no acupuncture will be done on this group of subjects but since they will be under general anesthesia they will not be aware that they are the control group
no acupuncture: placebo</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>patients undergoing thyroid or parathyroid surgery under general anesthesia</population>
      <group_list>
        <group group_id="B1">
          <title>Acupuncture</title>
          <description>acupuncture will be administered after induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes.
acupuncture: One half of subjects will receive a standardized acupuncture regiment</description>
        </group>
        <group group_id="B2">
          <title>Sham/Placebo</title>
          <description>no acupuncture will be done on this group of subjects. Since they are under general anesthesia they will not realize they are acting as control group
no acupuncture: placebo</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="11"/>
            <count group_id="B2" value="9"/>
            <count group_id="B3" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;45 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>45 years or older</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Reduced Pain Medication Requirement</title>
        <description>analgesia provided in Post Anesthesia Care Unit PACU)</description>
        <time_frame>amount of pain medication provided in PACU</time_frame>
        <population>All subjects enrolled in study</population>
        <group_list>
          <group group_id="O1">
            <title>Acupuncture</title>
            <description>acupuncture will be administered after induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes.
acupuncture: One half of subjects will receive a standardized acupuncture regiment</description>
          </group>
          <group group_id="O2">
            <title>Sham/Placebo</title>
            <description>no acupuncture will be done on this group of subjects. These subjects will be under general anesthesia and will not be aware that they are in control group.
no acupuncture: placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Reduced Pain Medication Requirement</title>
          <description>analgesia provided in Post Anesthesia Care Unit PACU)</description>
          <population>All subjects enrolled in study</population>
          <units>mg of Morphine</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.43" spread="1.70"/>
                    <measurement group_id="O2" value="7.36" spread="1.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity Score (VAS)</title>
        <description>VAS is a self reported pain scale with a score ranging from 0 to 10. 0= no pain, 10=worst pain possible. Multiple pain sacores were recorded. single value is reported by average</description>
        <time_frame>arrival in PACU to 2 hours post operatively</time_frame>
        <population>all study participants</population>
        <group_list>
          <group group_id="O1">
            <title>Acupuncture</title>
            <description>acupuncture will be administered after induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes.
acupuncture: One half of subjects will receive a standardized acupuncture regiment</description>
          </group>
          <group group_id="O2">
            <title>Sham/Placebo</title>
            <description>no acupuncture will be done on this group of subjects. These subjects will be under general anesthesia and will not be aware that they are in control group.
no acupuncture: placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity Score (VAS)</title>
          <description>VAS is a self reported pain scale with a score ranging from 0 to 10. 0= no pain, 10=worst pain possible. Multiple pain sacores were recorded. single value is reported by average</description>
          <population>all study participants</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.36" spread="0.97"/>
                    <measurement group_id="O2" value="6.67" spread="1.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>(ACTH )Adrenocorticotropic Hormone</title>
        <description>All blood samples were collected during general anesthesia, the first prior to surgical incision and electroacupuncture, the second 60 minutes after incision time and at the completion of electroacupuncture, the third after arrival in PACU but before the administration of analgesia. The data below represents female patients only</description>
        <time_frame>serum ACTH from baseline/preoperatively,intraoperatively, upon arrival in PACU</time_frame>
        <population>females</population>
        <group_list>
          <group group_id="O1">
            <title>Acupuncture</title>
            <description>acupuncture will be administered after induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes.
acupuncture: One half of subjects will receive a standardized acupuncture regiment</description>
          </group>
          <group group_id="O2">
            <title>Sham/Placebo</title>
            <description>no acupuncture will be done on this group of subjects. These subjects will be under general anesthesia and will not be aware that they are in control group.
no acupuncture: placebo</description>
          </group>
        </group_list>
        <measure>
          <title>(ACTH )Adrenocorticotropic Hormone</title>
          <description>All blood samples were collected during general anesthesia, the first prior to surgical incision and electroacupuncture, the second 60 minutes after incision time and at the completion of electroacupuncture, the third after arrival in PACU but before the administration of analgesia. The data below represents female patients only</description>
          <population>females</population>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>preoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.56" spread="2.60"/>
                    <measurement group_id="O2" value="21.32" spread="7.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>intraoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.26" spread="12.13"/>
                    <measurement group_id="O2" value="21.41" spread="8.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.36" spread="33.84"/>
                    <measurement group_id="O2" value="202" spread="74.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post op&lt;45years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="110" spread="88.94"/>
                    <measurement group_id="O2" value="276.1" spread="221.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>postop&gt;45 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.4" spread="8.09"/>
                    <measurement group_id="O2" value="177.3" spread="80.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>postop&lt;75kg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.03" spread="5.85"/>
                    <measurement group_id="O2" value="27.85" spread="14.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>postop&gt;75 kg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.48" spread="68.23"/>
                    <measurement group_id="O2" value="376.2" spread="73.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Morphine Equivalent</title>
        <description>All analgesic treatments were converted to morphine equivalents in milligrams .</description>
        <time_frame>PACU to 2 hours post op</time_frame>
        <population>females grouped by age (&lt;45 years and 45 years or greater)</population>
        <group_list>
          <group group_id="O1">
            <title>Acupuncture</title>
            <description>acupuncture will be administered after induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes.
acupuncture: One half of subjects will receive a standardized acupuncture regiment</description>
          </group>
          <group group_id="O2">
            <title>Sham/Placebo</title>
            <description>no acupuncture will be done on this group of subjects
no acupuncture: placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Morphine Equivalent</title>
          <description>All analgesic treatments were converted to morphine equivalents in milligrams .</description>
          <population>females grouped by age (&lt;45 years and 45 years or greater)</population>
          <units>mg of Morphine</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>&lt; 45 years old</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" spread="1.16"/>
                    <measurement group_id="O2" value="9.75" spread="2.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt; 45 years old</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" spread="2.52"/>
                    <measurement group_id="O2" value="6.68" spread="1.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Morphine Equivalent (mg)</title>
        <description>morphine equivalent to analyze whether body weight affected the efficacy of electroacupuncture</description>
        <time_frame>PACU arrival to 2 hours post op</time_frame>
        <population>females with body weight &lt;75 kg and &gt;than 75 kg</population>
        <group_list>
          <group group_id="O1">
            <title>Acupuncture</title>
            <description>acupuncture will be administered after induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes.
acupuncture: One half of subjects will receive a standardized acupuncture regiment</description>
          </group>
          <group group_id="O2">
            <title>Sham/Placebo</title>
            <description>no acupuncture will be done on this group of subjects
no acupuncture: placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Morphine Equivalent (mg)</title>
          <description>morphine equivalent to analyze whether body weight affected the efficacy of electroacupuncture</description>
          <population>females with body weight &lt;75 kg and &gt;than 75 kg</population>
          <units>mg morphine</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>&lt;75 kg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.25" spread="2.38"/>
                    <measurement group_id="O2" value="9.69" spread="1.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;75 kg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.63" spread="2.63"/>
                    <measurement group_id="O2" value="5.5" spread="2.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Modified Quality of Recovery Scale</title>
        <description>Modified patient self reported scale with 9 questions regarding general well being including ability to eat, free from constant pain, able to manage activities of daily living. 0= worst possible score and 18=best outcome score</description>
        <time_frame>Day 1, 2, 3</time_frame>
        <population>all females</population>
        <group_list>
          <group group_id="O1">
            <title>Acupuncture</title>
            <description>acupuncture will be administered after induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes.
acupuncture: One half of subjects will receive a standardized acupuncture regiment</description>
          </group>
          <group group_id="O2">
            <title>Sham/Placebo</title>
            <description>no acupuncture will be done on this group of subjects
no acupuncture: placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Modified Quality of Recovery Scale</title>
          <description>Modified patient self reported scale with 9 questions regarding general well being including ability to eat, free from constant pain, able to manage activities of daily living. 0= worst possible score and 18=best outcome score</description>
          <population>all females</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.5" spread="0.98"/>
                    <measurement group_id="O2" value="13.33" spread="0.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16" spread="0.73"/>
                    <measurement group_id="O2" value="15.89" spread="0.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.57" spread="0.3"/>
                    <measurement group_id="O2" value="17" spread="0.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cortisol</title>
        <description>All blood samples were collected during general anesthesia, the first prior to surgical incision and electroacupuncture, the second 60 minutes after incision time and at the completion of electroacupuncture, the third after arrival in PACU but before the administration of analgesia.</description>
        <time_frame>prior to surgical incision, 1 hour following incision, after arrival in PACU</time_frame>
        <population>females</population>
        <group_list>
          <group group_id="O1">
            <title>Acupuncture</title>
            <description>acupuncture will be administered after induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes.
acupuncture: One half of subjects will receive a standardized acupuncture regiment</description>
          </group>
          <group group_id="O2">
            <title>Sham/Placebo</title>
            <description>no acupuncture will be done on this group of subjects. These subjects will be under general anesthesia and will not be aware that they are in control group.
no acupuncture: placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Cortisol</title>
          <description>All blood samples were collected during general anesthesia, the first prior to surgical incision and electroacupuncture, the second 60 minutes after incision time and at the completion of electroacupuncture, the third after arrival in PACU but before the administration of analgesia.</description>
          <population>females</population>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>preoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="173.6" spread="83.3"/>
                    <measurement group_id="O2" value="155.2" spread="40.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>intraoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="103.1" spread="19.93"/>
                    <measurement group_id="O2" value="145.2" spread="26.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="267.4" spread="89.33"/>
                    <measurement group_id="O2" value="394.4" spread="104.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>postoperative&lt;45 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="375.6" spread="229.1"/>
                    <measurement group_id="O2" value="480" spread="302.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>postoperative&gt;45 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="202.4" spread="61.55"/>
                    <measurement group_id="O2" value="365.8" spread="116.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>postoperative&lt;75 kg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="252.1" spread="88.76"/>
                    <measurement group_id="O2" value="170.7" spread="67.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>postoperative&gt;75 kg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="296" spread="180.5"/>
                    <measurement group_id="O2" value="618.1" spread="114.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Morphine Equivalent</title>
        <description>equivalent doses of morphine for analgesic relief. All analgesic treatments were converted to morphine equivalents in milligrams.</description>
        <time_frame>PACU, day 1 , day 2, day 3</time_frame>
        <population>since gender impacts the threshold for analgesic and pain the effects of electroacupuncture on females was analyzed. The same number of females were in both groups but since one subject had preexisting levels of TNF&gt;1ug/ml prior to surgery she was eliminated from the dta base</population>
        <group_list>
          <group group_id="O1">
            <title>Acupuncture</title>
            <description>acupuncture will be administered after induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes.
acupuncture: One half of subjects will receive a standardized acupuncture regiment</description>
          </group>
          <group group_id="O2">
            <title>Sham/Placebo</title>
            <description>no acupuncture will be done on this group of subjects
no acupuncture: placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Morphine Equivalent</title>
          <description>equivalent doses of morphine for analgesic relief. All analgesic treatments were converted to morphine equivalents in milligrams.</description>
          <population>since gender impacts the threshold for analgesic and pain the effects of electroacupuncture on females was analyzed. The same number of females were in both groups but since one subject had preexisting levels of TNF&gt;1ug/ml prior to surgery she was eliminated from the dta base</population>
          <units>mg morphine</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PACU</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.19" spread="1.59"/>
                    <measurement group_id="O2" value="7.36" spread="1.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.31" spread="2.14"/>
                    <measurement group_id="O2" value="9" spread="2.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.84" spread="3.44"/>
                    <measurement group_id="O2" value="7.42" spread="2.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.93" spread="3.35"/>
                    <measurement group_id="O2" value="5.25" spread="2.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pain Levels</title>
        <description>Visual Acuity scale 0=no pain 10= worst pain possible</description>
        <time_frame>PACU, day 1 , day 2, day 3</time_frame>
        <population>female patients self reported pain experience following surgery</population>
        <group_list>
          <group group_id="O1">
            <title>Acupuncture</title>
            <description>acupuncture will be administered after induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes.
acupuncture: One half of subjects will receive a standardized acupuncture regiment</description>
          </group>
          <group group_id="O2">
            <title>Sham/Placebo</title>
            <description>no acupuncture will be done on this group of subjects
no acupuncture: placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Levels</title>
          <description>Visual Acuity scale 0=no pain 10= worst pain possible</description>
          <population>female patients self reported pain experience following surgery</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PACU</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.88" spread="1.29"/>
                    <measurement group_id="O2" value="6.67" spread="1.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.67" spread="1.09"/>
                    <measurement group_id="O2" value="5.56" spread="0.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>day2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" spread="1.09"/>
                    <measurement group_id="O2" value="5.93" spread="0.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>day3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.28" spread="0.95"/>
                    <measurement group_id="O2" value="3.33" spread="0.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Glucose</title>
        <description>the first two blood samples were collected during general anesthesia, the first prior to surgical incision and electroacupuncture, the second 60 minutes after incision time and at the completion of electroacupuncture, the third after arrival in PACU but before the administration of analgesia.</description>
        <time_frame>serum glucose from baseline to PACU arrival</time_frame>
        <population>females</population>
        <group_list>
          <group group_id="O1">
            <title>Acupuncture</title>
            <description>acupuncture will be administered after induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes.
acupuncture: One half of subjects will receive a standardized acupuncture regiment</description>
          </group>
          <group group_id="O2">
            <title>Sham/Placebo</title>
            <description>no acupuncture will be done on this group of subjects. These subjects will be under general anesthesia and will not be aware that they are in control group.
no acupuncture: placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Glucose</title>
          <description>the first two blood samples were collected during general anesthesia, the first prior to surgical incision and electroacupuncture, the second 60 minutes after incision time and at the completion of electroacupuncture, the third after arrival in PACU but before the administration of analgesia.</description>
          <population>females</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>preoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="150.4" spread="11.36"/>
                    <measurement group_id="O2" value="164.4" spread="10.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>intraoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="154.3" spread="8.75"/>
                    <measurement group_id="O2" value="187.1" spread="15.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="152.8" spread="7.76"/>
                    <measurement group_id="O2" value="208.1" spread="13.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post op &lt; 45 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="154.7" spread="9.39"/>
                    <measurement group_id="O2" value="190" spread="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post op &gt; 45 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="151.6" spread="11.88"/>
                    <measurement group_id="O2" value="213.3" spread="15.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>postop &lt;75 kg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="144.3" spread="7.22"/>
                    <measurement group_id="O2" value="210.3" spread="32.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post op &gt;75 kg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="148.5" spread="9.06"/>
                    <measurement group_id="O2" value="206.4" spread="2.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tumor Necrosis Factor (TNF)</title>
        <description>First two blood samples were collected during general anesthesia, first prior to surgical incision and Electro-acupuncture (EA), 2nd 60 minutes after incision and EA, third after arrival in PACU but before administration of analgesia. TNF is a critical pyrogen produced during acute phase of a reaction to trauma.</description>
        <time_frame>preoperatively-intraoperatively-postoperatively</time_frame>
        <population>female subjects</population>
        <group_list>
          <group group_id="O1">
            <title>Acupuncture</title>
            <description>acupuncture will be administered after induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes.
acupuncture: One half of subjects will receive a standardized acupuncture regiment</description>
          </group>
          <group group_id="O2">
            <title>Sham/Placebo</title>
            <description>no acupuncture will be done on this group of subjects
no acupuncture: placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Tumor Necrosis Factor (TNF)</title>
          <description>First two blood samples were collected during general anesthesia, first prior to surgical incision and Electro-acupuncture (EA), 2nd 60 minutes after incision and EA, third after arrival in PACU but before administration of analgesia. TNF is a critical pyrogen produced during acute phase of a reaction to trauma.</description>
          <population>female subjects</population>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>preoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.88" spread="0.67"/>
                    <measurement group_id="O2" value="2.14" spread="0.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>intraoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.09" spread="0.62"/>
                    <measurement group_id="O2" value="2.25" spread="0.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.98" spread="1.0"/>
                    <measurement group_id="O2" value="1.9" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>iNTERLEUKIN (IL-2 and IL-4)</title>
        <description>both are IL-2 and IL-4 are critical cytokines regulating the cellular response to induce cellular versus hormone immunity. First two blood samples were collected during general anesthesia: first prior to surgical incision and electroacupuncture, second 60 minutes after incision and electroacupuncture and the 3rd after arrival in PACU but before analgesia.</description>
        <time_frame>Preoperatively-intraoperatively-postoperatively</time_frame>
        <population>all females</population>
        <group_list>
          <group group_id="O1">
            <title>Acupuncture</title>
            <description>acupuncture will be administered after induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes.
acupuncture: One half of subjects will receive a standardized acupuncture regiment</description>
          </group>
          <group group_id="O2">
            <title>Sham/Placebo</title>
            <description>no acupuncture will be done on this group of subjects
no acupuncture: placebo</description>
          </group>
        </group_list>
        <measure>
          <title>iNTERLEUKIN (IL-2 and IL-4)</title>
          <description>both are IL-2 and IL-4 are critical cytokines regulating the cellular response to induce cellular versus hormone immunity. First two blood samples were collected during general anesthesia: first prior to surgical incision and electroacupuncture, second 60 minutes after incision and electroacupuncture and the 3rd after arrival in PACU but before analgesia.</description>
          <population>all females</population>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>IL-2preoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.64" spread="1.53"/>
                    <measurement group_id="O2" value="4.26" spread="3.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-2intraoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.38" spread="1.3"/>
                    <measurement group_id="O2" value="3.4" spread="2.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-2 postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.33" spread="1.31"/>
                    <measurement group_id="O2" value="2.77" spread="2.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-4 preoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.52" spread="0.15"/>
                    <measurement group_id="O2" value="0.59" spread="0.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-4 intraoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.57" spread="0.27"/>
                    <measurement group_id="O2" value="0.56" spread="0.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-4 postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.41" spread="0.12"/>
                    <measurement group_id="O2" value="0.37" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>IL-6</title>
        <description>First two blood samples were collected during general anesthesia, first prior to Surgical incision and EA, 2nd 60 minutes after incision and EA and the 3rd after arrival in PACU but before administration of analgesia. IL-6 is a critical inflammatory cytokine produced during the acute phase of reaction to trauma</description>
        <time_frame>Preoperatively-intraoperatively-postoperatively</time_frame>
        <population>total female results; then females divided into age groups (&lt;45 or &gt;45years) and weights groups (&lt;75kg and &gt;75kg)</population>
        <group_list>
          <group group_id="O1">
            <title>Acupuncture</title>
            <description>acupuncture will be administered after induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes.
acupuncture: One half of subjects will receive a standardized acupuncture regiment</description>
          </group>
          <group group_id="O2">
            <title>Sham/Placebo</title>
            <description>no acupuncture will be done on this group of subjects
no acupuncture: placebo</description>
          </group>
        </group_list>
        <measure>
          <title>IL-6</title>
          <description>First two blood samples were collected during general anesthesia, first prior to Surgical incision and EA, 2nd 60 minutes after incision and EA and the 3rd after arrival in PACU but before administration of analgesia. IL-6 is a critical inflammatory cytokine produced during the acute phase of reaction to trauma</description>
          <population>total female results; then females divided into age groups (&lt;45 or &gt;45years) and weights groups (&lt;75kg and &gt;75kg)</population>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>IL-6 preoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.58" spread="0.92"/>
                    <measurement group_id="O2" value="4.65" spread="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-6 intraoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.98" spread="1.1"/>
                    <measurement group_id="O2" value="4.66" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-6 postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.96" spread="10.35"/>
                    <measurement group_id="O2" value="27.45" spread="7.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-6 &lt;45 yrs post op</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.10" spread="5.3"/>
                    <measurement group_id="O2" value="30.9" spread="6.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-6 &gt;45 yrs postop</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.28" spread="16.97"/>
                    <measurement group_id="O2" value="26.46" spread="10.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-6 &lt;75 kg postop</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.15" spread="28.41"/>
                    <measurement group_id="O2" value="16" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-6 &gt;75 kg postop</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.44" spread="4.47"/>
                    <measurement group_id="O2" value="36.61" spread="12.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>IL-10</title>
        <description>IL-10 is an anti-inflammatory cytokine marker. First two blood samples were collected during general anesthesia, first prior to surgical incision and EA, 2nd 60 minutes following incision and EA, and the third after arrival in PACU but before administration of analgesia.</description>
        <time_frame>Preoperatively-intraoperatively-postoperatively</time_frame>
        <population>total females; then those grouped by age (&lt;45years and&gt;45 years) and weight (&lt;75 Kg and &gt;75kg)</population>
        <group_list>
          <group group_id="O1">
            <title>Acupuncture</title>
            <description>acupuncture will be administered after induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes.
acupuncture: One half of subjects will receive a standardized acupuncture regiment</description>
          </group>
          <group group_id="O2">
            <title>Sham/Placebo</title>
            <description>no acupuncture will be done on this group of subjects
no acupuncture: placebo</description>
          </group>
        </group_list>
        <measure>
          <title>IL-10</title>
          <description>IL-10 is an anti-inflammatory cytokine marker. First two blood samples were collected during general anesthesia, first prior to surgical incision and EA, 2nd 60 minutes following incision and EA, and the third after arrival in PACU but before administration of analgesia.</description>
          <population>total females; then those grouped by age (&lt;45years and&gt;45 years) and weight (&lt;75 Kg and &gt;75kg)</population>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>IL-10 preoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.35" spread="0.93"/>
                    <measurement group_id="O2" value="6.0" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL_10 intraoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.28" spread="1.62"/>
                    <measurement group_id="O2" value="7.81" spread="2.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-10 postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.15" spread="9.4"/>
                    <measurement group_id="O2" value="16.14" spread="4.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-10 &lt;45 yrs postop</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.23" spread="13.64"/>
                    <measurement group_id="O2" value="13.64" spread="10.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-10 &gt;45 postop</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.7" spread="1.19"/>
                    <measurement group_id="O2" value="16.86" spread="4.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-10 &lt;75kg postop</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.6" spread="1.6"/>
                    <measurement group_id="O2" value="10.7" spread="4.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-10&gt;75kg postop</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.18" spread="26.58"/>
                    <measurement group_id="O2" value="20.47" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>TGFB1</title>
        <description>TGFB1 is a pleiotropic factor regulating the immune system and healing. First two blood samples drawn under general anesthesia, first prior to surgical incision and EA, the 2nd 60 minutes after incision and EA, third after arrival in PACU but before administration of analgesia.</description>
        <time_frame>Preoperatively-intraoperatively-postoperatively</time_frame>
        <population>all females; then females by groups age (&lt;45 years and &gt;45 years) and weight (&lt;75kg and &gt;75kg)</population>
        <group_list>
          <group group_id="O1">
            <title>Acupuncture</title>
            <description>acupuncture will be administered after induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes.
acupuncture: One half of subjects will receive a standardized acupuncture regiment</description>
          </group>
          <group group_id="O2">
            <title>Sham/Placebo</title>
            <description>no acupuncture will be done on this group of subjects
no acupuncture: placebo</description>
          </group>
        </group_list>
        <measure>
          <title>TGFB1</title>
          <description>TGFB1 is a pleiotropic factor regulating the immune system and healing. First two blood samples drawn under general anesthesia, first prior to surgical incision and EA, the 2nd 60 minutes after incision and EA, third after arrival in PACU but before administration of analgesia.</description>
          <population>all females; then females by groups age (&lt;45 years and &gt;45 years) and weight (&lt;75kg and &gt;75kg)</population>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>preoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.30" spread="3.5"/>
                    <measurement group_id="O2" value="3.26" spread="1.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>intraoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.5" spread="6.28"/>
                    <measurement group_id="O2" value="9.4" spread="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.17" spread="8.8"/>
                    <measurement group_id="O2" value="12.9" spread="2.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&lt;45 yrs post op</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.76" spread="11.37"/>
                    <measurement group_id="O2" value="4.89" spread="0.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;45 yrs postop</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.2" spread="9.9"/>
                    <measurement group_id="O2" value="15.2" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&lt;75 kg postop</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.76" spread="13.51"/>
                    <measurement group_id="O2" value="13.96" spread="5.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;75kg postop</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.3" spread="9.2"/>
                    <measurement group_id="O2" value="12.11" spread="2.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Insulin Level</title>
        <description>to determine if electroacupuncture reduced hyperglycemia</description>
        <time_frame>preoperative and postoperative</time_frame>
        <population>female subjects preoperatively and postoperatively</population>
        <group_list>
          <group group_id="O1">
            <title>Acupuncture</title>
            <description>acupuncture will be administered after induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes.
acupuncture: One half of subjects will receive a standardized acupuncture regiment</description>
          </group>
          <group group_id="O2">
            <title>Sham/Placebo</title>
            <description>no acupuncture will be done on this group of subjects
no acupuncture: placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Insulin Level</title>
          <description>to determine if electroacupuncture reduced hyperglycemia</description>
          <population>female subjects preoperatively and postoperatively</population>
          <units>pg/ml</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>preoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="257.4" spread="92.8"/>
                    <measurement group_id="O2" value="378.1" spread="95.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="311.2" spread="50.59"/>
                    <measurement group_id="O2" value="325.4" spread="84.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 days postoperatively</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Acupuncture</title>
          <description>acupuncture will be administered after induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes.
acupuncture: One half of subjects will receive a standardized acupuncture regiment</description>
        </group>
        <group group_id="E2">
          <title>Sham/Placebo</title>
          <description>no acupuncture will be done on this group of subjects
no acupuncture: placebo</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dennis Grech, MD</name_or_title>
      <organization>Rutgers, The State University of New Jersey</organization>
      <phone>973 972-5007</phone>
      <email>grechde@njms.rutgers.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

